Literature DB >> 30797868

Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity.

F Caputo1, J Clogston2, L Calzolai3, M Rösslein4, A Prina-Mello5.   

Abstract

The particle size distribution (PSD) and the stability of nanoparticles enabled medicinal products (NEP) in complex biological environments are key attributes to assess their quality, safety and efficacy. Despite its low resolution, dynamic light scattering (DLS) is the most common sizing technique since the onset of NEP in pharmaceutical technologies. Considering the limitations of the existing sizing measurements and the challenges posed by complex NEPs both scientists and regulators encourage the combination of multiple orthogonal high-resolution approaches to shed light in the NEP sizing space (e.g. dynamic light scattering, electron microscopy, field flow fractionation coupled to online sizing detectors, centrifugal techniques, particle tracking analysis and tunable resistive pulse sensing). The pharmaceutical and biotechnology developers are now challenged to find their own pragmatic characterisation approaches, which should be fit for purpose and minimize costs at the same time, in a complicated landscape where only a few standards exist. In order to support the community, the European Nanomedicine Characterisation Laboratory (EUNCL) and the US National Cancer Institute Nanotechnology Characterization Laboratory (NCI-NCL) have jointly developed multiple standard operating procedures (SOPs) for NEP assessment, including the measurements of particle size distribution, and are offering wide access to their 'state of the art' characterisation platforms, in addition to making SOPs publicly available. This joint perspective article would like to present the NCI-NCL and EUNCL multi-step approach of incremental complexity to measure particle size distribution and size stability of NEPs, consisting of a quick preliminary step to assess sample integrity and stability by low resolution techniques (pre-screening), followed by the combination of complementary high resolution sizing measurements performed both in simple buffers and in complex biological media. Test cases are presented to demonstrate: i) the need for employing at least one high-resolution sizing technique, ii) the importance of selecting the correct sizing techniques for the purpose, and iii) the robustness of utilizing orthogonal sizing techniques to study the physical properties of complex NEP samples.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Morphology; Nanomedicine; Nanoparticles enabled medicinal products; Particle size distribution; Physico-chemical properties; Standard operating procedures (SOPs)

Mesh:

Year:  2019        PMID: 30797868     DOI: 10.1016/j.jconrel.2019.02.030

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  28 in total

1.  Can an InChI for Nano Address the Need for a Simplified Representation of Complex Nanomaterials across Experimental and Nanoinformatics Studies?

Authors:  Iseult Lynch; Antreas Afantitis; Thomas Exner; Martin Himly; Vladimir Lobaskin; Philip Doganis; Dieter Maier; Natasha Sanabria; Anastasios G Papadiamantis; Anna Rybinska-Fryca; Maciej Gromelski; Tomasz Puzyn; Egon Willighagen; Blair D Johnston; Mary Gulumian; Marianne Matzke; Amaia Green Etxabe; Nathan Bossa; Angela Serra; Irene Liampa; Stacey Harper; Kaido Tämm; Alexander CØ Jensen; Pekka Kohonen; Luke Slater; Andreas Tsoumanis; Dario Greco; David A Winkler; Haralambos Sarimveis; Georgia Melagraki
Journal:  Nanomaterials (Basel)       Date:  2020-12-11       Impact factor: 5.076

2.  On the issue of transparency and reproducibility in nanomedicine.

Authors:  Hon S Leong; Kimberly S Butler; C Jeffrey Brinker; May Azzawi; Steve Conlan; Christine Dufés; Andrew Owen; Steve Rannard; Chris Scott; Chunying Chen; Marina A Dobrovolskaia; Serguei V Kozlov; Adriele Prina-Mello; Ruth Schmid; Peter Wick; Fanny Caputo; Patrick Boisseau; Rachael M Crist; Scott E McNeil; Bengt Fadeel; Lang Tran; Steffen Foss Hansen; Nanna B Hartmann; Lauge P W Clausen; Lars M Skjolding; Anders Baun; Marlene Ågerstrand; Zhen Gu; Dimitrios A Lamprou; Clare Hoskins; Leaf Huang; Wantong Song; Huiliang Cao; Xuanyong Liu; Klaus D Jandt; Wen Jiang; Betty Y S Kim; Korin E Wheeler; Andrew J Chetwynd; Iseult Lynch; Seyed Moein Moghimi; André Nel; Tian Xia; Paul S Weiss; Bruno Sarmento; José das Neves; Hélder A Santos; Luis Santos; Samir Mitragotri; Steve Little; Dan Peer; Mansoor M Amiji; Maria José Alonso; Alke Petri-Fink; Sandor Balog; Aaron Lee; Barbara Drasler; Barbara Rothen-Rutishauser; Stefan Wilhelm; Handan Acar; Roger G Harrison; Chuanbin Mao; Priyabrata Mukherjee; Rajagopal Ramesh; Lacey R McNally; Sara Busatto; Joy Wolfram; Paolo Bergese; Mauro Ferrari; Ronnie H Fang; Liangfang Zhang; Jie Zheng; Chuanqi Peng; Bujie Du; Mengxiao Yu; Danielle M Charron; Gang Zheng; Chiara Pastore
Journal:  Nat Nanotechnol       Date:  2019-07       Impact factor: 39.213

3.  Peptide-siRNA nanoparticles targeting NF-κB p50 mitigate experimental abdominal aortic aneurysm progression and rupture.

Authors:  Huimin Yan; Ying Hu; Antonina Akk; Samuel A Wickline; Hua Pan; Christine T N Pham
Journal:  Biomater Adv       Date:  2022-07-02

Review 4.  Sizing up the Next Generation of Nanomedicines.

Authors:  Jeffrey D Clogston; Vincent A Hackley; Adriele Prina-Mello; Sanyogitta Puri; Silvia Sonzini; Patrick Lim Soo
Journal:  Pharm Res       Date:  2019-12-11       Impact factor: 4.200

Review 5.  Preparing (Metalla)carboranes for Nanomedicine.

Authors:  Marta Gozzi; Benedikt Schwarze; Evamarie Hey-Hawkins
Journal:  ChemMedChem       Date:  2021-03-19       Impact factor: 3.466

6.  Physical characterization of liposomal drug formulations using multi-detector asymmetrical-flow field flow fractionation.

Authors:  J Parot; F Caputo; D Mehn; V A Hackley; L Calzolai
Journal:  J Control Release       Date:  2020-01-28       Impact factor: 9.776

7.  Fast and Purification-Free Characterization of Bio-Nanoparticles in Biological Media by Electrical Asymmetrical Flow Field-Flow Fractionation Hyphenated with Multi-Angle Light Scattering and Nanoparticle Tracking Analysis Detection.

Authors:  Roland Drexel; Agnieszka Siupa; Pauline Carnell-Morris; Michele Carboni; Jo Sullivan; Florian Meier
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

8.  A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses.

Authors:  Giacomo Della Camera; Dorelia Lipsa; Dora Mehn; Paola Italiani; Diana Boraschi; Sabrina Gioria
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

9.  Bare plasmonic metal nanoparticles: synthesis, characterisation and in vitro toxicity assessment on a liver carcinoma cell line.

Authors:  Nabojit Das; Akash Kumar; Somendu Kumar Roy; Neeraj Kumar Satija; Rayavarapu Raja Gopal
Journal:  IET Nanobiotechnol       Date:  2020-12       Impact factor: 1.847

10.  Facile Synthesis of Zn-Doped Bi2O3 Nanoparticles and Their Selective Cytotoxicity toward Cancer Cells.

Authors:  Maqusood Ahamed; Mohd Javed Akhtar; M A Majeed Khan; ZabnAllah M Alaizeri; Hisham Alhadlaq
Journal:  ACS Omega       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.